Literature DB >> 23293720

Hepatocellular adenoma associated with familial adenomatous polyposis coli.

Keisuke Inaba1, Takanori Sakaguchi, Kiyotaka Kurachi, Hiroki Mori, Hong Tao, Toshio Nakamura, Yasuo Takehara, Satoshi Baba, Masato Maekawa, Haruhiko Sugimura, Hiroyuki Konno.   

Abstract

Hepatocellular adenoma (HCA) is a benign liver tumor that most frequently occurs in young women using oral contraceptives. We report a rare case of HCA in a 29 years old female with familial adenomatous polyposis (FAP). The first proband was her sister, who underwent a total colectomy and was genetically diagnosed as FAP. A tumor, 3.0 cm in diameter, was detected in the right lobe of the liver during a screening study for FAP. A colonoscopy and gastroendoscopy revealed numerous adenomatous polyps without carcinoma. The patient underwent a total colectomy and ileo-anal anastomosis and hepatic posterior sectoriectomy. The pathological findings of the liver tumor were compatible with HCA. The resected specimen of the colon revealed multiple colonic adenomatous polyps. Examination of genetic alteration revealed a germ-line mutation of the adenomatous polyposis coli (APC) gene. Inactivation of the second APC allele was not found. Other genetic alterations in the hepatocyte nuclear factor 1 alpha and β-catenin gene, which are reported to be associated with HCA, were not detected. Although FAP is reported to be complicated with various neoplasias in extracolic organs, only six cases of HCA associated with FAP, including the present case, have been reported. Additional reports will establish the precise mechanisms of HCA development in FAP patients.

Entities:  

Keywords:  Adenomatous polyposis coli gene; Extrahepatic manifestation; Familial adenomatous polyposis coli; Hepatic adenoma; Hepatocyte nuclear factor 1 alpha

Year:  2012        PMID: 23293720      PMCID: PMC3536841          DOI: 10.4254/wjh.v4.i11.322

Source DB:  PubMed          Journal:  World J Hepatol


  26 in total

Review 1.  The diagnosis and management of benign hepatic tumors.

Authors:  Bo Yoon Choi; Mindie H Nguyen
Journal:  J Clin Gastroenterol       Date:  2005 May-Jun       Impact factor: 3.062

2.  Changing causes of mortality in patients with familial adenomatous polyposis.

Authors:  L A Belchetz; T Berk; B V Bapat; Z Cohen; S Gallinger
Journal:  Dis Colon Rectum       Date:  1996-04       Impact factor: 4.585

3.  Familial adenomatous polyposis and extracolonic cancer.

Authors:  H T Lynch; A G Thorson; R D McComb; B A Franklin; S T Tinley; J F Lynch
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli.

Authors:  Emmanuelle Jeannot; Dominique Wendum; François Paye; Najat Mourra; Claudia de Toma; Jean-François Fléjou; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2006-10-04       Impact factor: 25.083

5.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

6.  Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis.

Authors:  A Nakao; K Sakagami; Y Nakata; K Komazawa; T Amimoto; K Nakashima; H Isozaki; N Takakura; N Tanaka
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

7.  Hepatocellular adenoma in a male with familial adenomatous polyposis coli.

Authors:  Yukiyasu Okamura; Atsuyuki Maeda; Kazuya Matsunaga; Hideyuki Kanemoto; Hiroyoshi Furukawa; Keiko Sasaki; Shigeki Yamaguchi; Katsuhiko Uesaka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-03-14

8.  Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.

Authors:  Hervé Laumonier; Paulette Bioulac-Sage; Christophe Laurent; Jessica Zucman-Rossi; Charles Balabaud; Hervé Trillaud
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

9.  Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Authors:  Jessica Zucman-Rossi; Emmanuelle Jeannot; Jeanne Tran Van Nhieu; Jean-Yves Scoazec; Catherine Guettier; Sandra Rebouissou; Yannick Bacq; Emmanuelle Leteurtre; Valérie Paradis; Sophie Michalak; Dominique Wendum; Laurence Chiche; Monique Fabre; Lucille Mellottee; Christophe Laurent; Christian Partensky; Denis Castaing; Elie Serge Zafrani; Pierre Laurent-Puig; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

10.  Biallelic inactivation of the APC gene in hepatoblastoma.

Authors:  H Kurahashi; K Takami; T Oue; T Kusafuka; A Okada; A Tawa; S Okada; I Nishisho
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

View more
  4 in total

Review 1.  Hepatocellular adenoma management: advances but still a long way to go.

Authors:  Jean Frédéric Blanc; Nora Frulio; Laurence Chiche; Paulette Bioulac-Sage; Charles Balabaud
Journal:  Hepat Oncol       Date:  2015-05-15

2.  TALEN-mediated somatic mutagenesis in murine models of cancer.

Authors:  Shuyuan Zhang; Lin Li; Sara L Kendrick; Robert D Gerard; Hao Zhu
Journal:  Cancer Res       Date:  2014-07-28       Impact factor: 12.701

Review 3.  Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis.

Authors:  Diane Goltz; Hans-Peter Fischer
Journal:  Int J Mol Sci       Date:  2015-09-02       Impact factor: 5.923

4.  Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.

Authors:  Elizabeth Margolskee; Fei Bao; Anne Koehne de Gonzalez; Roger K Moreira; Stephen Lagana; Anthony N Sireci; Antonia R Sepulveda; Helen Remotti; Jay H Lefkowitch; Marcela Salomao
Journal:  Diagn Pathol       Date:  2016-03-09       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.